Lee Chan Henry 4

4 · BeOne Medicines Ltd. · Filed Jul 10, 2026

AI-generated summary of this filing

Updated Jul 10, 2026

BeOne Medicines (ONC) SVP Lee Chan Henry Sells Shares, Exercises Options

What Happened

Lee Chan Henry, Senior Vice President and General Counsel of BeOne Medicines (ONC), executed several option/derivative transactions and sold shares on July 8, 2026. He exercised three derivative instruments to acquire a total of 664 shares at exercise prices of $194.47, $213.32 and $159.03 (total cash paid = $127,196). The same day he sold 664 shares in an open-market transaction at $302.46 each for proceeds of $200,833 (sale effected under a Rule 10b5-1 trading plan). The filing also reports conversion/settlement of additional derivative instruments (2,626; 3,458; and 2,548 units) shown as dispositions at $0.00, reflecting conversion/settlement rather than cash sales.

Key Details

Transaction date: July 8, 2026.
Exercised/acquired: 202 shares @ $194.47 ($39,283); 266 shares @ $213.32 ($56,743); 196 shares @ $159.03 ($31,170). Total paid = $127,196.
Sold: 664 shares @ $302.46, proceeds = $200,833. Sale under a Rule 10b5-1 plan adopted May 29, 2026 (Footnote F2).
Other derivative dispositions: 2,626; 3,458; 2,548 reported as disposed at $0.00 (these are conversions/settlements of derivative securities).
Footnote: Each American Depositary Share (ADS) represents 13 ordinary shares (F1). Vesting schedules for reported derivative awards are noted in F4–F6.
Shares owned after the transactions: not specified in the provided filing summary.
Filing timeliness: Report covers 07/08/2026 and was filed 07/10/2026 (timely Form 4 filing).

Context

Exercise vs sale: The filing shows option/derivative exercises (cash paid for exercise) and an immediate open-market sale of the same number of shares the same day. That pattern results in net proceeds (sale proceeds minus exercise cost) but is not by itself a statement of future sentiment. The sale was executed under a pre-established 10b5-1 plan (F2), which schedules trades in advance.
Zero-dollar "disposed" entries refer to conversion/settlement of derivative securities into underlying shares (not cash sales).
Be factual: these are company-reported transactions; motives are not disclosed.

Form 4

Period: 2026-07-08

SVP, General Counsel

Transactions

Exercise/Conversion
American Depositary Shares
[F1]
2026-07-08$194.47/sh+202$39,283→ 202 total
Exercise/Conversion
American Depositary Shares
[F1]
2026-07-08$213.32/sh+266$56,743→ 468 total
Exercise/Conversion
American Depositary Shares
[F1]
2026-07-08$159.03/sh+196$31,170→ 664 total
Sale
American Depositary Shares
[F1][F2]
2026-07-08$302.46/sh−664$200,833→ 0 total
Exercise/Conversion
Share Option (Right to Buy)
[F3][F4]
2026-07-08−2,626→ 17,238 total
Exercise: $14.96Exp: 2032-08-04→ Ordinary Shares (2,626 underlying)
Exercise/Conversion
Share Option (Right to Buy)
[F3][F5]
2026-07-08−3,458→ 79,768 total
Exercise: $16.41Exp: 2033-06-14→ Ordinary Shares (3,458 underlying)
Exercise/Conversion
Share Option (Right to Buy)
[F3][F6]
2026-07-08−2,548→ 105,300 total
Exercise: $12.23Exp: 2034-06-04→ Ordinary Shares (2,548 underlying)

Holdings

Footnotes (6)

[F1]Each American Depositary Share represents 13 Ordinary Shares.
[F2]The sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 29, 2026.
[F3]The number of securities underlying each option and the exercise price therefore are represented in ordinary shares.
[F4]These securities vest over a four-year period as follows: 25% on July 29, 2023 with the remaining shares vesting in 36 equal successive monthly installments thereafter, subject to continued service. Unvested securities are subject to accelerated vesting upon certain termination events.
[F5]These securities vest over a four-year period as follows: 25% on the first anniversary of June 15, 2023 with the remaining shares vesting in 36 equal successive monthly installments thereafter, subject to continued service. Unvested securities are subject to accelerated vesting upon certain termination events.
[F6]These securities vest over a four-year period as follows: 25% on the first anniversary of June 5, 2024 with the remaining shares vesting in 36 equal successive monthly installments thereafter, subject to continued service. Unvested securities are subject to accelerated vesting upon certain termination events.

Signature

/s/ Chan Henry Lee|2026-07-10

3 files